Consolidated figures
| Ratio | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|
| Margins | |||
| Gross margin % | 15.3% | 13.5% | 19.8% |
| EBITDA margin % | 7.2% | 5.8% | 11.5% |
Consolidated figures
| Ratio | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|
| Margins | |||
| Gross margin % | 15.3% | 13.5% | 19.8% |
| EBITDA margin % | 7.2% | 5.8% | 11.5% |
| EBIT margin % |
| 6% |
| 4.7% |
| 10.5% |
| PAT margin % | 3.5% | 2.5% | 6.8% |
| Working capital | |||
| Receivable days | 4 | 5 | 10 |
| Inventory days | 202 | 220 | 286 |
| Payable days | 17 | 10 | 37 |
| NWC days | 189 | 214 | 259 |
| Leverage | |||
| Current ratio | 1.55 | 1.69 | 1.54 |
| Debt to EBITDA | 3.99 | 4.81 | 1.62 |
| Debt to equity | 1.1 | 0.9 | 0.62 |
| Interest coverage | 3.3 | 2.6 | 4.7 |
| Asset turnover | 1.41 | 1.33 | 1.19 |
| Return ratios | |||
| Return on assets % | 4.9% | 3.4% | 8.1% |
| Return on capital employed % | 22.2% | 18.4% | 38% |
| Return on equity % | 13.3% | 8.1% | 22.8% |
Derived from reported annual statements. ROCE uses EBIT over capital employed (total assets less current liabilities). Day counts average the opening and closing balance; receivables turn on revenue, inventory and payables on cost of goods sold.